Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

35.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 373,908
  • Market Cap: £126.52m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,680,823
Richard John Rees 2,805,902 £982,066
Craig Jonathan Gulliford 1,630,466 £570,663
John Bradshaw 1,371,082 £479,879
David Gerard Woods 440,255 £154,089
Charles Spicer 308,530 £107,986
Ivonne Cantu 125,000 £43,750

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £13,756,072
Development Bank of Wales plc 14,376,727 £5,031,854
Finance Wales 12,776,727 £4,471,854
Baillie Gifford & Co 12,537,441 £4,388,104
Creo Medical Group EBT 10,000,000 £3,500,000
M&G Investments 9,428,500 £3,299,975
The Capital Group Companies, Inc. 8,816,807 £3,085,882
AXA Framlington Investment Managers 7,992,961 £2,797,536
Hargreave Hale Limited 6,753,632 £2,363,771
Tellworth Investments 5,772,778 £2,020,472
Hoya Corporation 4,799,880 £1,679,958
Jonathan Craton 3,400,294 £1,190,103
Cotterford Co Limited 3,335,398 £1,167,389
Mark Farmer 3,121,607 £1,092,562
RBC Trustees (CI) Ltd 2,974,727 £1,041,154
Angel Co Fund 2,967,120 £1,038,492

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 35.00p
Change Today -0.25p
% Change -0.71 %
52 Week High 48.10
52 Week Low 23.25
Volume 373,908
Shares Issued 361.48m
Market Cap £126.52m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
8.41% above the market average8.41% above the market average8.41% above the market average8.41% above the market average8.41% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Income Not Available
Growth
43.57% above the market average43.57% above the market average43.57% above the market average43.57% above the market average43.57% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:31 100,000 @ 34.63p
16:27 56,000 @ 35.48p
16:20 530 @ 35.45p
16:11 200 @ 35.45p
16:08 1,408 @ 35.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page